FDA Approved: CYCLOSPORINE — Supplemental Application (Apotex Corp)

View source ↗

Summary

The FDA approved a supplemental application for cyclosporine from Apotex Corp, authorizing changes under the generic product's regulatory filing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Graft-versus-host Disease
• Heart Transplant Rejection Prophylaxis
• Kidney Transplant Rejection Prophylaxis
• Liver Transplant Rejection Prophylaxis
• Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• CYCLOSPORINE (cyclosporine)

Snippet

SUPPL AP for CYCLOSPORINE (CYCLOSPORINE)